| Campylobacter coli |
Campylobacter coli |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Campylobacter coli |
Campylobacter coli |
MIC50 |
256.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Campylobacter coli |
Campylobacter coli |
MIC90 |
256.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Campylobacter jejuni |
Campylobacter jejuni |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Campylobacter jejuni |
Campylobacter jejuni |
MIC50 |
256.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Campylobacter jejuni |
Campylobacter jejuni |
MIC90 |
256.0 |
ug.mL-1 |
10.1128/aac.01655-08 |
| Cercopithecidae |
Monkey |
T1/2 |
0.5667 |
hr |
10.1021/jm00074a002 |
| Enterobacter |
Enterobacter |
MIC |
50.0 |
ug.mL-1 |
10.1021/jm00214a018 |
| Enterobacter cloacae |
Enterobacter cloacae |
MIC |
3.1 |
ug.mL-1 |
10.1021/jm00193a001 |
| Enterobacteriaceae |
Enterobacteriaceae |
MIC |
0.39 |
ug.mL-1 |
10.1021/jm00214a018 |
| Enterobacteriaceae |
Enterobacteriaceae |
MIC |
50.0 |
ug.mL-1 |
10.1021/jm00214a018 |
| Enterococcus |
Enterococcus |
MIC |
50.0 |
ug.mL-1 |
10.1021/jm00214a018 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1128/aac.01677-09 |
| Escherichia coli |
Escherichia coli |
MIC |
0.063 |
ug.mL-1 |
10.1128/aac.01677-09 |
| Escherichia coli |
Escherichia coli |
MIC |
0.13 |
ug.mL-1 |
10.1128/aac.01677-09 |
| Escherichia coli |
Escherichia coli |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.01677-09 |
| Escherichia coli |
Escherichia coli |
MIC |
0.39 |
ug.mL-1 |
10.1021/jm00214a018 |
| Escherichia coli |
Escherichia coli |
MIC |
0.4 |
ug.mL-1 |
10.1021/jm00193a001 |
| Escherichia coli |
Escherichia coli |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.ejmech.2012.03.008 |
| Escherichia coli |
Escherichia coli |
Ratio |
4.0 |
None |
10.1016/j.ejmech.2012.03.008 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
63.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-10.24 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.03 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
CL |
0.012 |
mL.min-1.kg-1 |
10.1124/dmd.112.049312 |
| Homo sapiens |
Homo sapiens |
CL |
0.048 |
mL.min-1.kg-1 |
10.1124/dmd.112.049312 |
| Homo sapiens |
Homo sapiens |
CL |
3.6 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
2.7 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
T1/2 |
0.8 |
hr |
10.1021/jm00074a002 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
8100000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
8100000.0 |
nM |
10.1021/jm048982w |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
9700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
1500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
1800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
3900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
2800000.0 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
2818382.93 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 22 member 11 |
Ki |
1140.0 |
nM |
10.1016/s0014-2999(02)01306-7 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
30.0 |
nM |
10.1016/s0014-2999(02)01306-7 |
| Homo sapiens |
Solute carrier family 22 member 7 |
IC50 |
1570000.0 |
nM |
10.1016/s0014-2999(03)01381-5 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
46.0 |
nM |
10.1016/s0014-2999(02)01306-7 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
30.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
16.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
2.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella |
Klebsiella |
MIC |
1.56 |
ug.mL-1 |
10.1021/jm00214a018 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
0.4 |
ug.mL-1 |
10.1021/jm00193a001 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00193a001 |
| Morganella morganii |
Morganella morganii |
MIC |
6.25 |
ug.mL-1 |
10.1021/jm00214a018 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Proteus mirabilis |
Proteus mirabilis |
MIC |
0.8 |
ug.mL-1 |
10.1021/jm00193a001 |
| Proteus mirabilis |
Proteus mirabilis |
MIC |
6.25 |
ug.mL-1 |
10.1021/jm00214a018 |
| Proteus vulgaris |
Proteus vulgaris |
MIC |
0.8 |
ug.mL-1 |
10.1021/jm00193a001 |
| Proteus vulgaris |
Proteus vulgaris |
MIC |
1.56 |
ug.mL-1 |
10.1021/jm00214a018 |
| Providencia |
Providencia |
MIC |
3.12 |
ug.mL-1 |
10.1021/jm00214a018 |
| Pseudomonas |
Pseudomonas |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00214a018 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00193a001 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Ki |
2800000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
5.0 |
mL.min-1.kg-1 |
10.1124/dmd.112.049312 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
29.41 |
mL.min-1.kg-1 |
10.1124/dmd.112.049312 |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
0.25 |
hr |
10.1021/jm00074a002 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
IC50 |
450000.0 |
nM |
10.1016/s0024-3205(02)01500-x |
| Rattus norvegicus |
Solute carrier family 22 member 7 |
IC50 |
3180000.0 |
nM |
10.1016/s0014-2999(03)01381-5 |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
IC50 |
90000.0 |
nM |
10.1016/s0024-3205(02)01500-x |
| Salmonella enterica |
Salmonella enterica |
MIC |
0.063 |
ug.mL-1 |
10.1128/aac.00371-09 |
| Salmonella enterica |
Salmonella enterica |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00371-09 |
| Salmonella enterica |
Salmonella enterica |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00371-09 |
| Salmonella enterica |
Salmonella enterica |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00371-09 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00079-09 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00079-09 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.00079-09 |
| Serratia |
Serratia |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00214a018 |
| Serratia marcescens |
Serratia marcescens |
MIC |
50.0 |
ug.mL-1 |
10.1021/jm00193a001 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Staphylococcus |
Staphylococcus |
Activity |
nan |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
FC |
1.2 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
FC |
2.0 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
MIC |
0.00025 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
MIC |
0.001 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
0.62 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
0.63 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
0.65 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
0.86 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
1.06 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
1.07 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
1.12 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
1.27 |
None |
10.1128/aac.00275-10 |
| Staphylococcus |
Staphylococcus |
Ratio |
1.29 |
None |
10.1128/aac.00275-10 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.00025 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.0005 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.001 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.1 |
ug.mL-1 |
10.1021/jm00193a001 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.39 |
ug.mL-1 |
10.1021/jm00214a018 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.4 |
ug.mL-1 |
10.1021/jm00193a001 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.4 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.6 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.3 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
13.6 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
4.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
8.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
16.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
1.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
64.0 |
ug.mL-1 |
10.1128/aac.00317-09 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
0.00025 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
0.0005 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
0.002 |
ug.mL-1 |
10.1128/aac.00275-10 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
0.1 |
ug.mL-1 |
10.1021/jm00193a001 |
| Streptococcus pyogenes |
Streptococcus pyogenes |
MIC |
0.39 |
ug.mL-1 |
10.1021/jm00214a018 |
| None |
ADMET |
CL |
3.6 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Drug excretion |
0.4 |
% |
10.1124/dmd.112.049312 |
| None |
ADMET |
Drug excretion |
33.0 |
% |
10.1124/dmd.112.049312 |
| None |
ADMET |
MRT |
0.75 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
0.75 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.16 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1128/aac.00427-09 |
| None |
NON-PROTEIN TARGET |
Fu |
0.25 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
2.4 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
13.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
75.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
pKa |
3.4 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa_A1 |
3.29 |
None |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |